Antiretroviral drug resistance in human immunodeficiency virus type 2.
Ntemgwa
Michel L
ML
McGill University AIDS Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
d'Aquin Toni
Thomas
T
Brenner
Bluma G
BG
Camacho
Ricardo J
RJ
Wainberg
Mark A
MA
D000998:Antiviral Agents / Q000494:pharmacology*; D024882:Drug Resistance, Viral / Q000235:genetics / Q000502:physiology*; D016333:HIV Protease / Q000737:chemistry / Q000235:genetics; D017320:HIV Protease Inhibitors / Q000494:pharmacology; D015498:HIV-2 / Q000187:drug effects* / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D012194:RNA-Directed DNA Polymerase / Q000737:chemistry / Q000235:genetics
D000998:Antiviral Agents; D017320:HIV Protease Inhibitors; D012194:RNA-Directed DNA Polymerase; D016333:HIV Protease